TA}3Z~%QPF5}[J(_O65Y5<~
SYSTEM PROCESSING...
TA}3Z~%QPF5}[J(_O65Y5<~
SYSTEM PROCESSING...
Posted: 2025-03-20 23:07:53 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-03-20 23:09:26 UTC
Verified By
Rollup News
US regulators have approved the first-ever treatment for Hutchinson-Guilford Progeria, a rare disease causing rapid aging in children. The oral medication, lonafarnib, extends the lifespan of children affected by the disease by 2.5 years on average.